# Exor Ventures

> Exor Ventures is a VC fund in Amsterdam backing Software and Health Care. See 107 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Amsterdam, The Netherlands
- Total investments: 107
- Last investment: Sep 2025
- Lead investor: 19%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/exor_2
- Website: https://www.exor.com/pages/companies-investments/ventures

Exor Ventures is a VC fund in Amsterdam focused on Software and Health Care. Exor Ventures is the venture capital arm of Exor, one of Europe's largest diversified holding companies. Exor Ventures focuses on early and growth-stage investments in technology-driven companies across various sectors, including digital services, fintech, cybersecurity, and mobility. Exor Ventures leverages its strategic insights and globalnetwork to identify promising startups with disruptive potential and supports them through funding, mentorship, and access to its extensive resources. EXOR Seeds offers a truly different type of partnership to the select group of entrepreneurs that it backs:- As a fifth-generation family-led business, we proved that we are builders not traders;- Our permanent capital allows us to take a long-term view and put the interest of the companies We invest in first;- Our global network, across industries and geographies, is a unique advantage to entrepreneurs

## Contacts

5 contacts available for Exor Ventures. Shizune tracks 2 team members at Exor Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/exor-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.8M–$26M |
| Pre-Seed | $320k–$6.3M |
| Series A | $5.8M–$55M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 21 | 20% |
| Health Care | 14 | 13% |
| FinTech | 12 | 11% |
| Artificial Intelligence | 12 | 11% |
| Information Technology | 11 | 10% |

134 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 29 | 27% |
| Pre-Seed | 21 | 20% |
| Series A | 19 | 18% |
| Series B | 11 | 10% |
| Series C | 8 | 7% |

12 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 26 | 24% |
| Italy | 23 | 21% |
| France | 11 | 10% |
| United Kingdom | 11 | 10% |
| Switzerland | 3 | 3% |

15 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Noam Ohana | Managing Director | 34 | https://shizune.co/investors/profile/noam-ohana |
| Omry Czapnik | Investor | 0 | https://shizune.co/investors/profile/omry-czapnik |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Plino | Plino is the SMEs FP&A co-pilot, integrating your company data and making it faster and easier to analyse them, empowering entrepreneurs in taking successful informed decisions. On one side it collects, organizes and analyses data from different company’s data sources such as invoices, bank accounts, MES, ERP, WMS, industry 4.0 data, andcompany documents (contracts, technical data sheets). On the other, it provides a user-friendly chat where the user (either the entrepreneur, the CFO, or the accountant) can type questions and receive fast, precise and insightful answers on the company’s revenues, costs, clients, products, and production process. Its mission is to empower SME’s managers to take better informed strategic decisions to lead the company to scale toward success by overcoming market uncertainty. | $764.6K | Pre-Seed | Sep 15, 2025 |  |
| PhaseV | PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution,enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner. | $50M | Series A | May 13, 2025 |  |
| HypeSound | Hypesound is revolutionizing the fermentation industry with its innovative sound wave technology. The company is utilizing sonic technology to boost the productivity of algae, yeast, and bacteria, paving the way for sustainable bioproduction and the next industrial revolution. | $1.3M | Pre-Seed | Mar 24, 2025 |  |
| Byzantine Finance | Byzantine is the gateway infrastructure for restaking. We enable anyone to build customizable restaking vaults that give them full control over their risks and rewards. The Byzantine protocol is designed to make risk management of restaking strategies permissionless and flexible allowing for a more competitive, risk-optimised yield. | $3M | Pre-Seed | Feb 25, 2025 |  |
| N5 Now | N5 Now is a create your own digital ecosystem with a platform designed exclusively for the financial industry. | $20M | Series B | Feb 20, 2025 |  |
| Focoos AI | Focoos AI simplifies and accelerates the adoption of artificial vision by offering a platform equipped with ready-to-use neural networks that are easily adaptable to user needs, significantly reducing development time and costs. | $2.8M | Seed | Feb 19, 2025 |  |
| Almanax | Almanax provides AI-powered security tools for web3. | $1M | Venture - Series Unknown | Jan 22, 2025 |  |
| Tracer Biotechnologies | Tracer Biotechnologies is a biotechnology company that offers monitoring services for oncology patients. | $10M | Series A | Dec 12, 2024 |  |
| Scalestack | Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline. | $3M | Seed | Dec 05, 2024 |  |
| Volta | Volta is a developer of software-as-a-service platform focusing on B2B commerce. | $6.3M | Pre-Seed | Nov 25, 2024 |  |

10 of 107 investments shown.

## Co-investors
- [EXOR N.V.](https://shizune.co/investors/profile/exor-s-p-a) — VC Fund, 99 deals together
- [Exor Ventures](https://shizune.co/investors/profile/exor-seeds) — VC Fund, 91 deals together
- [Index Ventures](https://shizune.co/investors/profile/index-ventures) — VC Fund, 9 deals together
- [2100 Ventures](https://shizune.co/investors/profile/2100-ventures) — VC Fund, 7 deals together
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund, 6 deals together
- [Ithaca Investments](https://shizune.co/investors/profile/ithaca-investments) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [All Investors in Italy](https://shizune.co/investors/investors-italy)
- [All VC Funds in Italy](https://shizune.co/investors/vc-funds-italy)
- [Software VC Funds in Italy](https://shizune.co/investors/software-vc-funds-italy)
- [SaaS Investors in Italy](https://shizune.co/investors/saas-investors-italy)
- [SaaS VC Funds in Italy](https://shizune.co/investors/saas-vc-funds-italy)
- [Enterprise Investors in Italy](https://shizune.co/investors/enterprise-investors-italy)

## FAQ

### What does Exor Ventures invest in?

Exor Ventures invests primarily in Software, Health Care and FinTech startups, most often at Seed and Pre-Seed stage. Most of the 107 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Exor Ventures's check size?

Exor Ventures typically joins rounds of $1.8M–$26M at Seed, $320k–$6.3M at Pre-Seed and $5.8M–$55M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Exor Ventures participates in.

### How do I contact Exor Ventures?

Public channels for Exor Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Exor Ventures?

The team at Exor Ventures includes Noam Ohana (Managing Director) and Omry Czapnik (Investor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co